GALEAS ™ Bladder service
An end-to-end service – from sample through to report – based on our simple urine GALEAS ™ Bladder test for the detection and monitoring of bladder cancer that delivers results equivalent to a cystoscopy.
Hereditary Cancer services
Our end-to-end, ISO 15189:2022 accredited Hereditary Cancer services aim to identify individuals at a higher-than-population risk for hereditary cancer
